BamSEC and AlphaSense Join Forces
Learn More

OptimizeRx Corporation – Material Contracts

NASDAQ: OPRX    
Share price (5/22/26): $4.94    
Market cap (5/22/26): $92.7 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.24
from 10-K 155 pages Material contract
12/34/56
EX-10.18
from 10-K 22 pages Amended and Restated OptimizeRx Corporation Executive Severance Plan* Plan Document/Summary Plan Description
12/34/56
EX-10.1
from 8-K 3 pages Amended and Restated Employment Letter, Dated as of August 18, 2025 by and Between the Company and Brendan Merrell
12/34/56
EX-10.22
from 10-K 9 pages Amendment No. 3 to Financing Agreement
12/34/56
EX-10.21
from 10-K 10 pages Amendment No. 2 to Financing Agreement
12/34/56
EX-10.19
from 10-K 19 pages Amended OptimizeRx Corporation Executive Severance Plan* Plan Document/Summary Plan Description
12/34/56
EX-10.1
from 8-K 8 pages March 7, 2025 Stephen Silvestro Xxxx Xxxx
12/34/56
EX-10.1
from 8-K 11 pages December 19, 2024 William Febbo XXX XXX XXX Re: Separation Agreement and Release of Claims; Advisory Terms & Conditions 1. Separation; Notice; Employment Status; Benefits Eligibility. Your Employment With the Company Will Terminate on December 31, 2024 (The “Separation Date”)
12/34/56
EX-10.1
from 8-K 1 page Amendment No.1 to the OptimizeRx Corporation 2021 Equity Incentive Plan
12/34/56
EX-10.28
from 10-K 20 pages OptimizeRx Corporation Executive Severance Plan* Plan Document/Summary Plan Description
12/34/56
EX-10.27
from 10-K 8 pages Amended and Restated Employment Agreement by and Between the Company and Stephen Silvestro Dated April 12, 2024
12/34/56
EX-10.26
from 10-K 7 pages Fifth Addendum to the Employment Agreement With William J. Febbo Dated April 12, 2024
12/34/56
EX-10.1
from 8-K 9 pages Amendment No. 1 to Financing Agreement
12/34/56
EX-10.1
from 8-K 6 pages Common Stock Purchase Agreement
12/34/56
EX-10.4
from 8-K 5 pages Fee Letter
12/34/56
EX-10.3
from 8-K 133 pages Financing Agreement Dated as of October 11, 2023 by and Among OptimizeRx Corporation, as the Lead Borrower, the Lenders From Time to Time Party Hereto, as Lenders, and Blue Torch Finance, LLC, as Administrative Agent and Collateral Agent
12/34/56
EX-10.2
from 8-K 9 pages Joinder and Support Agreement to Agreement and Plan of Merger
12/34/56
EX-10.1
from 8-K 77 pages Agreement and Plan of Merger by and Among OptimizeRx Corporation, Healthy Offers, Inc., the Securityholders of Healthy Offers, Inc., and Michael Weintraub, as Securityholder Representative Dated as of October 11, 2023
12/34/56
EX-10.19
from 10-K 2 pages March 8, 2023 Mr. William Febbo Re: Fourth Addendum to the Offer Letter, Dated February 25, 2019, as Amended, by and Between William Febbo and OptimizeRx Corporation Change in Control Termination
12/34/56
EX-10.18
from 10-K 19 pages OptimizeRx Corporation Executive Severance Plan Plan Document/Summary Plan Description
12/34/56